Computer vision app allows easier monitoring of diabetes

November 13, 2020

A computer vision technology developed by University of Cambridge engineers has now been developed into a free mobile phone app for regular monitoring of glucose levels in people with diabetes.

The app uses computer vision techniques to read and record the glucose levels, time and date displayed on a typical glucose test via the camera on a mobile phone. The technology, which doesn't require an internet or Bluetooth connection, works for any type of glucose meter, in any orientation and in a variety of light levels. It also reduces waste by eliminating the need to replace high-quality non-Bluetooth meters, making it a cost-effective solution to the NHS.

Working with UK glucose testing company GlucoRx, the Cambridge researchers have developed the technology into a free mobile phone app, called GlucoRx Vision, which is now available on the Apple App Store and Google Play Store.

To use the app, users simply take a picture of their glucose meter and the results are automatically read and recorded, allowing much easier monitoring of blood glucose levels.

In addition to the glucose meters which people with diabetes use on a daily basis, many other types of digital meters are used in the medical and industrial sectors. However, many of these meters still do not have wireless connectivity, so connecting them to phone tracking apps often requires manual input.

"These meters work perfectly well, so we don't want them sent to landfill just because they don't have wireless connectivity," said Dr James Charles from Cambridge's Department of Engineering. "We wanted to find a way to retrofit them in an inexpensive and environmentally-friendly way using a mobile phone app."

In addition to his interest in solving the challenge from an engineering point of view, Charles also had a personal interest in the problem. He has type 1 diabetes and needs to take as many as ten glucose readings per day. Each reading is then manually entered into a tracking app to help determine how much insulin he needs to regulate his blood glucose levels.

"From a purely selfish point of view, this was something I really wanted to develop," he said.

"We wanted something that was efficient, quick and easy to use," said Professor Roberto Cipolla, also from the Department of Engineering. "Diabetes can affect eyesight or even lead to blindness, so we needed the app to be easy to use for those with reduced vision."

The computer vision technology behind the GlucoRx app is made up of two steps. First, the screen of the glucose meter is detected. The researchers used a single training image and augmented it with random backgrounds, particularly backgrounds with people. This helps ensure the system is robust when the user's face is reflected in the phone's screen.

Second, a neural network called LeDigit detects each digit on the screen and reads it. The network is trained with computer-generated synthetic data, avoiding the need for labour-intensive labelling of data which is commonly needed to train a neural network.

"Since the font on these meters is digital, it's easy to train the neural network to recognise lots of different inputs and synthesise the data," said Charles. "This makes it highly efficient to run on a mobile phone."

"It doesn't matter which orientation the meter is in - we tested it in all types of orientations, viewpoints and light levels," said Cipolla, who is also a Fellow of Jesus College. "The app will vibrate when it's read the information, so you get a clear signal when you've done it correctly. The system is accurate across a range of different types of meters, with read accuracies close to 100%"

In addition to blood glucose monitor, the researchers also tested their system on different types of digital meters, such as blood pressure monitors, kitchen and bathroom scales. The researchers also recently presented their results at the 31st British Machine Vision Conference.

Gluco-Rx initially approached Cipolla's team in 2018 to develop a cost-effective and environmentally-friendly solution to the problem of non-connected glucose meters, and once the technology had been shown to be sufficiently robust, the company worked with the Cambridge researchers to develop the app.

"We have been working in partnership with Cambridge University on this unique solution, which will help change the management of diabetes for years to come," said Chris Chapman, Chief Operating Officer of GlucoRx. "We will soon make this solution available to all of our more than 250,000 patients."

As for Charles, who has been using the app to track his glucose levels, he said it "makes the whole process easier. I've now forgotten what it was like to enter the values in manually, but I do know I wouldn't want to go back to it. There are a few areas in the system which could still be made even better, but all in all I'm very happy with the outcome."

University of Cambridge

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to